vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and Sezzle Inc. (SEZL). Click either name above to swap in a different company.
Sezzle Inc. is the larger business by last-quarter revenue ($135.5M vs $62.1M, roughly 2.2× Cytek Biosciences, Inc.). Sezzle Inc. runs the higher net margin — 37.9% vs -70.9%, a 108.8% gap on every dollar of revenue. On growth, Sezzle Inc. posted the faster year-over-year revenue change (29.2% vs 8.1%). Over the past eight quarters, Sezzle Inc.'s revenue compounded faster (111.9% CAGR vs 17.7%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Sezzle is a publicly traded financial technology company headquartered in Minneapolis, U.S, with operations in the United States and Canada. The company provides an alternative payment platform offering interest-free installment plans at selected online stores. As of June 2021, the Sezzle platform had over 10 million user sign-ups and over 48,000 participating merchants.
CTKB vs SEZL — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $135.5M |
| Net Profit | $-44.1M | $51.3M |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | 50.9% |
| Net Margin | -70.9% | 37.9% |
| Revenue YoY | 8.1% | 29.2% |
| Net Profit YoY | -557.1% | 41.9% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $135.5M | ||
| Q4 25 | $62.1M | $78.2M | ||
| Q3 25 | $52.3M | $57.5M | ||
| Q2 25 | $45.6M | $52.0M | ||
| Q1 25 | $41.5M | $48.2M | ||
| Q4 24 | $57.5M | $48.4M | ||
| Q3 24 | $51.5M | $35.6M | ||
| Q2 24 | $46.6M | $30.2M |
| Q1 26 | — | $51.3M | ||
| Q4 25 | $-44.1M | $42.7M | ||
| Q3 25 | $-5.5M | $26.7M | ||
| Q2 25 | $-5.6M | $27.6M | ||
| Q1 25 | $-11.4M | $36.2M | ||
| Q4 24 | $9.6M | $25.4M | ||
| Q3 24 | $941.0K | $15.4M | ||
| Q2 24 | $-10.4M | $29.7M |
| Q1 26 | — | — | ||
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — |
| Q1 26 | — | 50.9% | ||
| Q4 25 | -9.0% | 70.6% | ||
| Q3 25 | -17.6% | 61.9% | ||
| Q2 25 | -23.3% | 69.4% | ||
| Q1 25 | -36.1% | — | ||
| Q4 24 | 5.2% | 63.8% | ||
| Q3 24 | -8.2% | 58.6% | ||
| Q2 24 | -18.3% | 55.3% |
| Q1 26 | — | 37.9% | ||
| Q4 25 | -70.9% | 54.6% | ||
| Q3 25 | -10.5% | 46.4% | ||
| Q2 25 | -12.2% | 53.1% | ||
| Q1 25 | -27.5% | 75.1% | ||
| Q4 24 | 16.8% | 52.4% | ||
| Q3 24 | 1.8% | 43.4% | ||
| Q2 24 | -22.4% | 98.4% |
| Q1 26 | — | — | ||
| Q4 25 | — | $1.19 | ||
| Q3 25 | — | $0.75 | ||
| Q2 25 | — | $0.78 | ||
| Q1 25 | — | $1.00 | ||
| Q4 24 | — | $0.71 | ||
| Q3 24 | — | $0.44 | ||
| Q2 24 | — | $0.82 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $196.7M |
| Total Assets | $461.5M | $454.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $90.9M | $64.1M | ||
| Q3 25 | $93.3M | $104.1M | ||
| Q2 25 | $75.5M | $88.9M | ||
| Q1 25 | $95.3M | $88.9M | ||
| Q4 24 | $98.7M | $73.2M | ||
| Q3 24 | $162.3M | $80.1M | ||
| Q2 24 | $177.9M | $58.0M |
| Q1 26 | — | $196.7M | ||
| Q4 25 | $341.7M | $169.8M | ||
| Q3 25 | $378.6M | $155.3M | ||
| Q2 25 | $377.6M | $130.4M | ||
| Q1 25 | $379.6M | $125.8M | ||
| Q4 24 | $395.7M | $87.8M | ||
| Q3 24 | $385.5M | $61.1M | ||
| Q2 24 | $389.1M | $50.3M |
| Q1 26 | — | $454.3M | ||
| Q4 25 | $461.5M | $400.2M | ||
| Q3 25 | $494.9M | $367.0M | ||
| Q2 25 | $493.3M | $350.6M | ||
| Q1 25 | $482.6M | $298.1M | ||
| Q4 24 | $499.5M | $298.4M | ||
| Q3 24 | $491.2M | $252.9M | ||
| Q2 24 | $483.7M | $212.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | — |
| Free Cash FlowOCF − Capex | $-1.8M | — |
| FCF MarginFCF / Revenue | -2.9% | — |
| Capex IntensityCapex / Revenue | 1.6% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-771.0K | $70.6M | ||
| Q3 25 | $-3.9M | $63.7M | ||
| Q2 25 | $108.0K | $23.1M | ||
| Q1 25 | $-125.0K | $52.5M | ||
| Q4 24 | $2.0M | $57.4M | ||
| Q3 24 | $13.2M | $35.1M | ||
| Q2 24 | $6.2M | $22.2M |
| Q1 26 | — | — | ||
| Q4 25 | $-1.8M | $70.6M | ||
| Q3 25 | $-4.6M | $63.6M | ||
| Q2 25 | $-1.5M | $22.7M | ||
| Q1 25 | $-974.0K | $52.5M | ||
| Q4 24 | $1.1M | $57.4M | ||
| Q3 24 | $12.2M | $35.1M | ||
| Q2 24 | $5.2M | $22.2M |
| Q1 26 | — | — | ||
| Q4 25 | -2.9% | 90.2% | ||
| Q3 25 | -8.7% | 110.6% | ||
| Q2 25 | -3.2% | 43.6% | ||
| Q1 25 | -2.3% | 108.9% | ||
| Q4 24 | 1.9% | 118.5% | ||
| Q3 24 | 23.7% | 98.6% | ||
| Q2 24 | 11.0% | 73.4% |
| Q1 26 | — | — | ||
| Q4 25 | 1.6% | 0.1% | ||
| Q3 25 | 1.3% | 0.3% | ||
| Q2 25 | 3.5% | 0.8% | ||
| Q1 25 | 2.0% | 0.1% | ||
| Q4 24 | 1.6% | 0.1% | ||
| Q3 24 | 2.0% | 0.0% | ||
| Q2 24 | 2.3% | 0.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.65× | ||
| Q3 25 | — | 2.39× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 1.45× | ||
| Q4 24 | 0.21× | 2.26× | ||
| Q3 24 | 14.05× | 2.27× | ||
| Q2 24 | — | 0.75× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
SEZL
Segment breakdown not available.
